After the international thematic conferences in Dessau (2006), San Francisco (2009), Brussels (2014 and 2015), Berlin (2016), Copenhagen (2017), Rotterdam (2018), Wroclaw (2019) and Athens (2020) we had planed to organize the 10th International EHSF Conference as a worldwide face-to-face event.

The pandemic has obliged us, however, to offer a virtual event, which is a new experience for us and, despite of that, is not going to limit our target to provide a high level scientific event on the ongoing and future research development and innovations on HS. Moreover, we want to achieve our initial purpose to encourage international cooperation in the field.

Since the legentary, pioneer days many things have changed to the better. The interest to the disease and the scientific work performed by increasing numbers of clinician and scientists have grown exponentially.

HS has found its home in dermatology. Patients have been organized in several national self-aid groups. A first compound for medical treatment has been registered with many more currently being into clinical studies. At last, the EHSF e.V. has grown up, providing significant contributions in the field through valuable cooperative works of its members in discovering the molecular etiology, comorbid factors and biomarkers, and establishing diagnostic and classification criteria, outcome measure instruments and guidelines for the treatment of the disease.